miR-346 Inhibited Apoptosis Against Myocardial Ischemia-Reperfusion Injury via Targeting Bax in Rats

References

• ZhaiC, QianQ, TangG, et al. MicroRNA-206 protects against myocardial ischaemia-reperfusion injury in rats by targeting Gadd45beta. Mol Cells. 2017;40(12):916–924. doi:10.14348/molcells.2017.016429237256
   PubMed Web of Science ®Google Scholar
• ThindGS, AgrawalPR, HirshB, et al. Mechanisms of myocardial ischemia-reperfusion injury and the cytoprotective role of minocycline: scope and limitations. Future Cardiol. 2015;11(1):61–76. doi:10.2217/fca.14.7625606703
   PubMed Web of Science ®Google Scholar
• HeB, XiaoJ, RenAJ, et al. Role of miR-1 and miR-133a in myocardial ischemic postconditioning. J Biomed Sci. 2011;18:22. doi:10.1186/1423-0127-18-2221406115
   PubMed Web of Science ®Google Scholar
• EltzschigHK, EckleT. Ischemia and reperfusion–from mechanism to translation. Nat Med. 2011;17(11):1391–1401. doi:10.1038/nm.250722064429
   PubMed Web of Science ®Google Scholar
• YangJ, FanZ, YangJ, DingJ, YangC, ChenL. microRNA-22 attenuates myocardial ischemia-reperfusion injury via an anti-inflammatory mechanism in rats. Exp Ther Med. 2016;12(5):3249–3255. doi:10.3892/etm.2016.377727882145
   PubMed Web of Science ®Google Scholar
• BotkerHE, HausenloyD, AndreadouI, et al. Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection. Basic Res Cardiol. 2018;113(5):39.30120595
   PubMed Web of Science ®Google Scholar
• DiazI, Calderon-SanchezE, ToroRD, et al. miR-125a, miR-139 and miR-324 contribute to Urocortin protection against myocardial ischemia-reperfusion injury. Sci Rep. 2017;7(1):8898. doi:10.1038/s41598-017-09198-x28827743
   PubMed Web of Science ®Google Scholar
• MakhdoumiP, RoohbakhshA, KarimiG. MicroRNAs regulate mitochondrial apoptotic pathway in myocardial ischemia-reperfusion-injury. Biomed Pharmacother. 2016;84:1635–1644. doi:10.1016/j.biopha.2016.10.07327829552
   PubMed Web of Science ®Google Scholar
• WuHH, HsiaoTY, ChienCT, LaiMK. Ischemic conditioning by short periods of reperfusion attenuates renal ischemia/reperfusion induced apoptosis and autophagy in the rat. J Biomed Sci. 2009;16:19. doi:10.1186/1423-0127-16-1919272187
   PubMed Web of Science ®Google Scholar
• ZhouH, ZhuP, WangJ, ZhuH, RenJ, ChenY. Pathogenesis of cardiac ischemia reperfusion injury is associated with CK2alpha-disturbed mitochondrial homeostasis via suppression of FUNDC1-related mitophagy. Cell Death Differ. 2018;25(6):1080–1093. doi:10.1038/s41418-018-0086-729540794
   PubMed Web of Science ®Google Scholar
• TianY, LvW, LuC, ZhaoX, ZhangC, SongH. LATS2 promotes cardiomyocyte H9C2 cells apoptosis via the Prx3-Mfn2-mitophagy pathways. J Recept Signal Transduct Res. 2019;39(5–6):470–478. doi:10.1080/10799893.2019.170103131829064
   PubMed Web of Science ®Google Scholar
• ZhuH, FanGC. Role of microRNAs in the reperfused myocardium towards post-infarct remodelling. Cardiovasc Res. 2012;94(2):284–292. doi:10.1093/cvr/cvr29122038740
   PubMed Web of Science ®Google Scholar
• TanH, QiJ, FanBY, ZhangJ, SuFF, WangHT. MicroRNA-24-3p attenuates myocardial ischemia/reperfusion injury by suppressing RIPK1 expression in mice. Cell Physiol Biochem. 2018;51(1):46–62. doi:10.1159/00049516130439713
   PubMedGoogle Scholar
• DiYF, LiDC, ShenYQ, et al. MiR-146b protects cardiomyocytes injury in myocardial ischemia/reperfusion by targeting Smad4. Am J Transl Res. 2017;9(2):656–663.28337293
   PubMed Web of Science ®Google Scholar
• BartelDP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297. doi:10.1016/S0092-8674(04)00045-514744438
   PubMed Web of Science ®Google Scholar
• DoenchJG, SharpPA. Specificity of microRNA target selection in translational repression. Genes Dev. 2004;18(5):504–511. doi:10.1101/gad.118440415014042
   PubMed Web of Science ®Google Scholar
• ZhangB, PanX, CobbGP, AndersonTA. microRNAs as oncogenes and tumor suppressors. Dev Biol. 2007;302(1):1–12. doi:10.1016/j.ydbio.2006.08.02816989803
   PubMed Web of Science ®Google Scholar
• ShenoudaSK, AlahariSK. MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer Metastasis Rev. 2009;28(3–4):369–378. doi:10.1007/s10555-009-9188-520012925
   PubMed Web of Science ®Google Scholar
• ZuoY, WangY, HuH, CuiW. Atorvastatin protects myocardium against ischemia-reperfusion injury through inhibiting miR-199a-5p. Cell Physiol Biochem. 2016;39(3):1021–1030. doi:10.1159/00044780927537066
   PubMedGoogle Scholar
• WangX, ZhangX, RenXP, et al. MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury. Circulation. 2010;122(13):1308–1318. doi:10.1161/CIRCULATIONAHA.110.96468420837890
   PubMed Web of Science ®Google Scholar
• ZhuY, KalbfleischT, BrennanMD, LiY. A MicroRNA gene is hosted in an intron of a schizophrenia-susceptibility gene. Schizophr Res. 2009;109(1–3):86–89. doi:10.1016/j.schres.2009.01.02219264453
   PubMed Web of Science ®Google Scholar
• WeberF, TeresiRE, BroelschCE, FrillingA, EngC. A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma. J Clin Endocrinol Metab. 2006;91(9):3584–3591. doi:10.1210/jc.2006-069316822819
   PubMed Web of Science ®Google Scholar
• MiaoX, WuX, ShiW. MicroRNA-346 regulates neural stem cell proliferation and differentiation by targeting KLF4. Am J Transl Res. 2017;9(12):5400–5410.29312492
   PubMed Web of Science ®Google Scholar
• OskowitzAZ, LuJ, PenfornisP, et al. Human multipotent stromal cells from bone marrow and microRNA: regulation of differentiation and leukemia inhibitory factor expression. Proc Natl Acad Sci U S A. 2008;105(47):18372–18377. doi:10.1073/pnas.080980710519011087
   PubMed Web of Science ®Google Scholar
• ZhuW, QianJ, MaL, MaP, YangF, ShuY. miR-346 suppresses cell proliferation through SMYD3 dependent approach in hepatocellular carcinoma. Oncotarget. 2017;8(39):65218–65229. doi:10.18632/oncotarget.1806029029425
   PubMedGoogle Scholar
• SemaanN, FrenzelL, AlsalehG, et al. miR-346 controls release of TNF-alpha protein and stability of its mRNA in rheumatoid arthritis via tristetraprolin stabilization. PLoS One. 2011;6(5):e19827. doi:10.1371/journal.pone.001982721611196
   PubMed Web of Science ®Google Scholar
• ChenB, PanW, LinX, et al. MicroRNA-346 functions as an oncogene in cutaneous squamous cell carcinoma. Tumour Biol. 2016;37(2):2765–2771. doi:10.1007/s13277-015-4046-226408183
   PubMedGoogle Scholar
• YanHL, LiL, LiSJ, ZhangHS, XuW. miR-346 promotes migration and invasion of nasopharyngeal carcinoma cells via targeting BRMS1. J Biochem Mol Toxicol. 2016;30(12):602–607. doi:10.1002/jbt.2016.30.issue-1227501413
   PubMed Web of Science ®Google Scholar
• ZhangWP, ZongQF, GaoQ, et al. Effects of endomorphin-1 postconditioning on myocardial ischemia/reperfusion injury and myocardial cell apoptosis in a rat model. Mol Med Rep. 2016;14(4):3992–3998. doi:10.3892/mmr.2016.569527600942
   PubMed Web of Science ®Google Scholar
• VasevaAV, MollUM. The mitochondrial p53 pathway. Biochim Biophys Acta. 2009;1787(5):414–420. doi:10.1016/j.bbabio.2008.10.00519007744
   PubMed Web of Science ®Google Scholar
• ZhouM, LiuZ, ZhaoY, et al. MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J Biol Chem. 2010;285(28):21496–21507. doi:10.1074/jbc.M109.08333720460378
   PubMed Web of Science ®Google Scholar
• AnejaR, HakePW, BurroughsTJ, DenenbergAG, WongHR, ZingarelliB. Epigallocatechin, a green tea polyphenol, attenuates myocardial ischemia reperfusion injury in rats. Mol Med. 2004;10(1–6):55–62. doi:10.2119/2004-00032.Aneja15502883
   PubMed Web of Science ®Google Scholar
• Fernandez-JimenezR, Garcia-PrietoJ, Sanchez-GonzalezJ, et al. Pathophysiology underlying the bimodal edema phenomenon after myocardial ischemia/reperfusion. J Am Coll Cardiol. 2015;66(7):816–828. doi:10.1016/j.jacc.2015.06.02326271065
   PubMed Web of Science ®Google Scholar
• HeuschG. 25 years of remote ischemic conditioning: from laboratory curiosity to clinical outcome. Basic Res Cardiol. 2018;113(3):15. doi:10.1007/s00395-018-0673-229516255
   PubMed Web of Science ®Google Scholar
• ChangJC, HuWF, LeeWS, et al. Intermittent hypoxia induces autophagy to protect cardiomyocytes from endoplasmic reticulum stress and apoptosis. Front Physiol. 2019;10:995. doi:10.3389/fphys.2019.0099531447690
   PubMed Web of Science ®Google Scholar
• ParadiesG, ParadiesV, RuggieroFM, PetrosilloG. Mitochondrial bioenergetics and cardiolipin alterations in myocardial ischemia-reperfusion injury: implications for pharmacological cardioprotection. Am J Physiol Heart Circ Physiol. 2018;315(5):H1341–H1352. doi:10.1152/ajpheart.00028.201830095969
   PubMed Web of Science ®Google Scholar
• YuL, ZhangW, HuangC, et al. FoxO4 promotes myocardial ischemia-reperfusion injury: the role of oxidative stress-induced apoptosis. Am J Transl Res. 2018;10(9):2890–2900.30323875
   PubMed Web of Science ®Google Scholar
• JinQ, LiR, HuN, et al. DUSP1 alleviates cardiac ischemia/reperfusion injury by suppressing the Mff-required mitochondrial fission and Bnip3-related mitophagy via the JNK pathways. Redox Biol. 2018;14:576–587. doi:10.1016/j.redox.2017.11.00429149759
   PubMed Web of Science ®Google Scholar
• O’NeillLA, SheedyFJ, McCoyCE. MicroRNAs: the fine-tuners of toll-like receptor signalling. Nat Rev Immunol. 2011;11(3):163–175. doi:10.1038/nri295721331081
   PubMed Web of Science ®Google Scholar
• O’ConnellRM, RaoDS, ChaudhuriAA, BaltimoreD. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol. 2010;10(2):111–122. doi:10.1038/nri270820098459
   PubMed Web of Science ®Google Scholar
• LongH, WangX, ChenY, WangL, ZhaoM, LuQ. Dysregulation of microRNAs in autoimmune diseases: pathogenesis, biomarkers and potential therapeutic targets. Cancer Lett. 2018;428:90–103. doi:10.1016/j.canlet.2018.04.01629680223
   PubMed Web of Science ®Google Scholar
• EvangelatosG, FragoulisGE, KoulouriV, LambrouGI. MicroRNAs in rheumatoid arthritis: from pathogenesis to clinical impact. Autoimmun Rev. 2019;102391. doi:10.1016/j.autrev.2019.10239131520804
   PubMed Web of Science ®Google Scholar
• GottliebRA, PourpiraliS. Lost in translation: miRNAs and mRNAs in ischemic preconditioning and ischemia/reperfusion injury. J Mol Cell Cardiol. 2016;95:70–77. doi:10.1016/j.yjmcc.2015.11.01126582464
   PubMed Web of Science ®Google Scholar
• HuJ, GaoC, WeiC, et al. RBFox2-miR-34a-Jph2 axis contributes to cardiac decompensation during heart failure. Proc Natl Acad Sci U S A. 2019;116(13):6172–6180. doi:10.1073/pnas.182217611630867288
   PubMed Web of Science ®Google Scholar
• LiJ, CaiSX, HeQ, et al. Intravenous miR-144 reduces left ventricular remodeling after myocardial infarction. Basic Res Cardiol. 2018;113(5):36. doi:10.1007/s00395-018-0694-x30084039
   PubMed Web of Science ®Google Scholar
• HeallenTR, KadowZA, KimJH, WangJ, MartinJF. Stimulating cardiogenesis as a treatment for heart failure. Circ Res. 2019;124(11):1647–1657. doi:10.1161/CIRCRESAHA.118.31357331120819
   PubMed Web of Science ®Google Scholar
• NattelS. Molecular and cellular mechanisms of atrial fibrosis in atrial fibrillation. JACC Clin Electrophysiol. 2017;3(5):425–435. doi:10.1016/j.jacep.2017.03.00229759598
   PubMedGoogle Scholar
• ChinchillaA, DaimiH, Lozano-VelascoE, et al. PITX2 insufficiency leads to atrial electrical and structural remodeling linked to arrhythmogenesis. Circ Cardiovasc Genet. 2011;4(3):269–279. doi:10.1161/CIRCGENETICS.110.95811621511879
   PubMedGoogle Scholar
• HuangK, O’NeillKL, LiJ, et al. BH3-only proteins target BCL-xL/MCL-1, not BAX/BAK, to initiate apoptosis. Cell Res. 2019;29:942–952. doi:10.1038/s41422-019-0231-y31551537
   PubMed Web of Science ®Google Scholar
• MatarreseP, TieriP, AnticoliS, et al. X-chromosome-linked miR548am-5p is a key regulator of sex disparity in the susceptibility to mitochondria-mediated apoptosis. Cell Death Dis. 2019;10(9):673. doi:10.1038/s41419-019-1888-331511496
   PubMed Web of Science ®Google Scholar
• JezekJ, ChangKT, JoshiAM, StrichR. Mitochondrial translocation of cyclin C stimulates intrinsic apoptosis through Bax recruitment. EMBO Rep. 2019;20(9):e47425. doi:10.15252/embr.20184742531385392
   PubMed Web of Science ®Google Scholar
• MaG, LiuY. NURR1 inhibition reduces hypoxia-mediated cardiomyocyte necrosis via blocking Mst1-JNK-mPTP pathway. J Recept Signal Transduct Res. 2019;39(4):350–358. doi:10.1080/10799893.2019.169051431755334
   PubMed Web of Science ®Google Scholar